Perspectives on SARS-CoV-2 Main Protease Inhibitors-Reference-Cited by-同舟云学术

Perspectives on SARS-CoV-2 Main Protease Inhibitors

Published:2021-11-19 Issue:23 Volume:64 Page:16922-16955
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Gao Kaifu¹^ORCID,Wang Rui¹^ORCID,Chen Jiahui¹^ORCID,Tepe Jetze J.²^ORCID,Huang Faqing³,Wei Guo-Wei¹⁴⁵^ORCID

Affiliation:

1. Department of Mathematics, Michigan State University, East Lansing, Michigan 48824, United States

2. Department of Chemistry and Pharmacology & Toxicology, Michigan State University, East Lansing, Michigan 48824, United States

3. Department of Chemistry and Biochemistry, University of Southern Mississippi, Hattiesburg, Mississippi 39406, United States

4. Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan 48824, United States

5. Department of Electrical and Computer Engineering, Michigan State University, East Lansing, Michigan 48824, United States

Funder

Division of Mathematical Sciences

Pfizer

Bristol-Myers Squibb

Michigan Economic Development Corporation

National Aeronautics and Space Administration

George Mason University

National Institute of General Medical Sciences

Division of Information and Intelligent Systems

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c00409

Reference155 articles.

1. COVID-19 vaccine development and a potential nanomaterial path forward

2. Zimmer, C.; Corum, J.; Wee, S.L. Coronavirus Vaccine Tracker. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html, 2020.

3. Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries

4. A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2

5. Halford, B. Pfizer unveils its oral SARS-CoV-2 inhibitor. https://cen.acs.org/acs-news/acs-meeting-news/Pfizer-unveils-oral-SARS-CoV/99/i13, 2020.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the potent covalent inhibitor with an acrylate warhead for SARS-CoV-2 3CL protease;Bioorganic & Medicinal Chemistry Letters;2024-11

2. How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents;European Journal of Medicinal Chemistry;2024-11

3. N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL protease;European Journal of Medicinal Chemistry;2024-10

4. Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS‐CoV‐2 main protease;Archiv der Pharmazie;2024-08-15

5. Breaking the Chain: Protease Inhibitors as Game Changers in Respiratory Viruses Management;International Journal of Molecular Sciences;2024-07-25